Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Symposia

New familial endocrine cancer syndromes: pathophysiology and counselling

ea0029s40.1 | New familial endocrine cancer syndromes: pathophysiology and counselling | ICEECE2012

DICER1 mutations characterize a novel syndrome with endocrine features

Wu M. , Priest J. , Hamel N. , Sabbaghian N. , Xu B. , Tischkowitz M. , Choong C. , Deal C. , Albrecht S. , Charles A. , Goodyer P. , Foulkes W.

DICER1 is a microRNA processing-RNase III-type endoribonuclease and is crucial for embryogenesis and early development. Nearly 50 different heterozygous germ-line DICER1 mutations have been reported world-wide in individuals who developed, as children or young adults, pleuropulmonary blastoma, cystic nephroma, ovarian sex cord stromal tumors (especially Sertoli–Leydig cell tumor), multi-nodular goiter, embryonal rhabdomyosarcoma (of cervix and other typical sites), Wilms ...

ea0029s40.2 | New familial endocrine cancer syndromes: pathophysiology and counselling | ICEECE2012

The paediatric patient with paraganglioma syndrome

Robledo M.

Pheochromocytomas and paragangliomas (PCC/PGL) are rare tumours of the adrenal gland or derived from sympathetic and parasympathetic paraganglia occurring sporadically or as part of a familial cancer syndrome. Up to 20% of them are diagnosed in children, and they are not genetically well characterized. As most are functional tumors, children more often present with signs and symptoms related to hypertension. In fact, sustained hypertension is found in more than 60–90% of ...

ea0029s40.3 | New familial endocrine cancer syndromes: pathophysiology and counselling | ICEECE2012

Li-Fraumeni Syndrome: A paradigm of genetic testing to clinical surveillance for pediatric endocrine tumors

Malkin D.

Li Fraumeni syndrome (LFS) is a prototypic cancer predisposition syndrome, characterized by multiple, early-onset malignant tumours including breast cancer, bone and soft tissue sarcomas, brain tumors and adrenocortical carcinoma (ACC). LFS is most commonly attributed to germline mutations in the TP53 tumor-suppressor gene. p53 activity is tightly regulated by multiple post-translational mechanisms, disruption of which may lead to tumorigenesis. ACC occurs at disproportionatel...